Skip to content

Wave Life Sciences WVE Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-53.7%-56.2%
Return on assets-42.1%-41.3%
Liquidity
Current ratio11.3×+8.3×6.5×+3.6×2.5×+0.6×2.6×+1.6×+1.8×
Quick ratio11.3×+8.3×6.5×+3.6×2.5×+0.6×2.6×+1.6×+1.8×
Cash ratio10.9×+8.1×6.3×+3.6×2.3×+0.5×2.4×+1.5×2.8×+1.7×
Leverage
Debt-to-equity-0.1×-0.1×0.2×0.0×0.2×0.1×-1.1×
Debt-to-assets-0.1×0.0×0.1×0.0×0.1×-0.1×0.1×0.0×
Per Share
Book value per share$2.56+142%$3.07+103%$0.74-30.5%$0.85+3,269%$1.06+438%
Valuation
Market capitalization$1.14B+13.0%$3.16B+67.4%$1.17B+9.7%$1.06B+64.7%$1.24B+83.3%
Enterprise value$615.92M-22.3%$2.57B+59.9%$989.1M+27.1%$875.72M+68.4%$1.02B+94.0%
Price / book2.2×-3.7×6.1×-2.9×9.4×+1.9×7.6×7.2×-19.4×
Free cash flow yield-16.2%+1.7pp-6%+2.1pp-17%-3.6pp-18.8%-14.6%
Earnings yield-16%-6.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Wave Life Sciences's ratios come from?
Every ratio is computed from Wave Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.